Evidence map›Paper›PMID 32923129›Full record

ArticleOncoimmunology2020

Cancer immunotherapy using a polysaccharide from

Hae-Bin Park, Seong-Min Lim, Juyoung Hwang, Wei Zhang, SangGuan You, Jun-O Jin

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Molecular therapy oncolytics · 2021
    Article
  9. Intranasal Administration ofInternational journal of molecular sciences · 2021
    Article
  10. Article
  11. Journal for immunotherapy of cancer · 2021
    Article
  12. Review
  13. Polysaccharide fromMarine drugs · 2020
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hae-Bin ParkShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.ORCID 0000-0001-6481-2321
Seong-Min LimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, South Korea.
Juyoung HwangShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.ORCID 0000-0001-7569-9010
Wei ZhangShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
SangGuan YouDepartment of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung, South Korea.
Jun-O JinShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.ORCID 0000-0003-4216-8111
Fudan University · CNGangneung–Wonju National University · KRYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural polysaccharides have shown immune modulatory effects with low toxicity in both animal and human models. A previous study has shown that the polysaccharide from Abbreviations: CFP:

Indexed as

ImmunotherapyNeoplasmsAnimalsChinaDisease Models, AnimalMiceMice, Inbred BALB CMice, Inbred C57BLPolysaccharidesPolysaccharidesadjuvantanti-cancerCodium fragile polysaccharidecytotoxic T lymphocytedendritic cellhelper T cell

Identifiers

PMID32923129
PMCPMC7458636
OpenAlexW3033946268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.